Rho kinase blockade prevents inflammation via nuclear factor κB inhibition: evidence in Crohn’s disease and experimental colitis
- 1 May 2003
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 124 (5), 1180-1187
- https://doi.org/10.1016/s0016-5085(03)00283-x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's diseaseGut, 2000
- Cyclic GMP-dependent Protein Kinase Signaling Pathway Inhibits RhoA-induced Ca2+ Sensitization of Contraction in Vascular Smooth MuscleJournal of Biological Chemistry, 2000
- Stimulation of NFκB Activity by Multiple Signaling Pathways Requires PAK1Journal of Biological Chemistry, 2000
- TNBS-ColitisInternational Reviews of Immunology, 2000
- The IL-1 receptor and Rho directly associate to drive cell activation in inflammationJournal of Clinical Investigation, 1999
- Multiple Signalling Pathways Lead to the Activation of the Nuclear Factor κB by the Rho Family of GTPasesPublished by Elsevier ,1998
- Activation of nuclear factor kappa B in inflammatory bowel diseaseGut, 1998
- Identification and Characterization of an IκB KinaseCell, 1997
- Isolation and functional characterization of human intestinal mucosal lymphoid cells.Journal of Clinical Investigation, 1977